2011 ONS Annual Congress Coverage

ONS Annual Congress 2011

Managing viral infections in severely immunocompromised patients

Oncology nurses play a vital role in patient care, including assessment, early recognition of infections, and patient and family education. Providing evidence-based care and education to severely immunocompromised patients requires knowledge about the association between viruses and diseases, the rationale of specific diagnostic tests, and current treatments.

Oncology FBI team helps promote a culture of safety

Monitoring infection rates and introducing interventions to eliminate central line-associated bloodstream infections (CLABSIs), a serious safety concern for hospitalized oncology patients, is one way nursing care can be advanced in complex health care environments that support a culture of safety, according to a presentation at the Oncology Nursing Society 36th Annual Congress.

“Distress thermometer” screening tool can improve outcomes in patients with pancreatic cancer

Patients with pancreatic cancer frequently experience high levels of anxiety and distress, in part because the disease carries a poor prognosis, necessitating frequent clinic visits. To help identify and characterize patient distress, the University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, has utilized a distress thermometer (DT) screening tool at each clinic visit since 2005, according to a presentation at the Oncology Nursing Society 36th Annual Congress.

Changing practice behaviors reduces central line-associated bloodstream infections

The effects of cancer treatment place patients at high risk for central line-associated blood stream infections (CLABSIs), which directly reflect the care provided at the time of insertion and through the lifetime of the central line. These infections are a significant cause of morbidity, mortality, and increased health care costs. These are the findings of a study presented at the Oncology Nursing Society 36th Annual Congress.

Nilotinib provides durable responses in patients with newly diagnosed chronic myeloid leukemia in chronic phase

Results of an 18-month evaluation in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) presented during the Oncology Nursing Society 36th Annual Congress continue to confirm the superior efficacy of nilotinib to imatinib. Although imatinib has long been considered the standard of care for the frontline treatment of CML-CP, clinical evidence shows some patients have inadequate response, develop resistance, or develop intolerable side effects.

Nurses in ideal position to deliver messages that increase HPV vaccine acceptability

Nurses should be aware of a stigma surrounding human papillomavirus (HPV) vaccination and factor that into communications with patients, Cheryl S. Lee, MS, RN, ACNP-BC, MD Anderson Cancer Center, Houston, Texas, said in presenting a systematic review of how messages about the HPV vaccine are framed during the Oncology Nursing Society 36th Annual Congress.

Next post in ONS Annual Congress 2011